Annual Net Income
-$18.55 M
-$981.10 K-5.59%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual net profit is -$18.55 million, with the most recent change of -$981.10 thousand (-5.59%) on December 1, 2023.
- During the last 3 years, RNAZ annual net income has fallen by -$16.20 million (-691.25%).
- RNAZ annual net income is now -2954.36% below its all-time high of -$607.20 thousand, reached on December 31, 2019.
Performance
RNAZ Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$2.32 M
+$2.87 M+55.28%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly net profit is -$2.32 million, with the most recent change of +$2.87 million (+55.28%) on September 1, 2024.
- Over the past year, RNAZ quarterly net income has increased by +$2.98 million (+56.20%).
- RNAZ quarterly net income is now -183.78% below its all-time high of $2.77 million, reached on June 30, 2021.
Performance
RNAZ Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$14.93 M
+$2.98 M+16.64%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ TTM net profit is -$14.93 million, with the most recent change of +$2.98 million (+16.64%) on September 1, 2024.
- Over the past year, RNAZ TTM net income has increased by +$4.67 million (+23.82%).
- RNAZ TTM net income is now -36041.65% below its all-time high of -$41.30 thousand, reached on March 1, 2020.
Performance
RNAZ TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RNAZ Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -5.6% | +56.2% | +23.8% |
3 y3 years | -691.3% | +0.4% | -208.0% |
5 y5 years | -2954.4% | -5520.8% | -10000.0% |
RNAZ Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -171.0% | at low | at high | +56.2% | -156.1% | +23.8% |
5 y | 5-year | -2954.4% | at low | -183.8% | +56.2% | <-9999.0% | +23.8% |
alltime | all time | -2954.4% | at low | -183.8% | +56.2% | <-9999.0% | +23.8% |
TransCode Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$2.32 M(-55.3%) | -$14.93 M(-16.6%) |
Jun 2024 | - | -$5.19 M(+56.0%) | -$17.91 M(+5.0%) |
Mar 2024 | - | -$3.33 M(-18.6%) | -$17.06 M(-8.0%) |
Dec 2023 | -$18.55 M(+5.6%) | -$4.09 M(-22.9%) | -$18.55 M(-5.3%) |
Sep 2023 | - | -$5.30 M(+22.1%) | -$19.59 M(+5.4%) |
Jun 2023 | - | -$4.34 M(-9.9%) | -$18.58 M(-1.7%) |
Mar 2023 | - | -$4.82 M(-6.2%) | -$18.91 M(+7.7%) |
Dec 2022 | -$17.57 M | -$5.13 M(+19.7%) | -$17.57 M(+15.3%) |
Sep 2022 | - | -$4.29 M(-8.2%) | -$15.23 M(+14.8%) |
Jun 2022 | - | -$4.67 M(+34.6%) | -$13.27 M(+127.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$3.47 M(+24.0%) | -$5.83 M(-14.8%) |
Dec 2021 | -$6.84 M(+192.0%) | -$2.80 M(+20.2%) | -$6.84 M(+41.2%) |
Sep 2021 | - | -$2.33 M(-184.1%) | -$4.85 M(+24.6%) |
Jun 2021 | - | $2.77 M(-161.8%) | -$3.89 M(-42.7%) |
Mar 2021 | - | -$4.49 M(+459.6%) | -$6.79 M(+189.6%) |
Dec 2020 | -$2.34 M(+286.0%) | - | - |
Dec 2020 | - | -$801.50 K(-41.7%) | -$2.34 M(+52.0%) |
Sep 2020 | - | -$1.37 M(+980.1%) | -$1.54 M(+815.4%) |
Jun 2020 | - | -$127.20 K(+208.0%) | -$168.50 K(+308.0%) |
Mar 2020 | - | -$41.30 K | -$41.30 K |
Dec 2019 | -$607.20 K | - | - |
FAQ
- What is TransCode Therapeutics annual net profit?
- What is the all time high annual net income for TransCode Therapeutics?
- What is TransCode Therapeutics annual net income year-on-year change?
- What is TransCode Therapeutics quarterly net profit?
- What is the all time high quarterly net income for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly net income year-on-year change?
- What is TransCode Therapeutics TTM net profit?
- What is the all time high TTM net income for TransCode Therapeutics?
- What is TransCode Therapeutics TTM net income year-on-year change?
What is TransCode Therapeutics annual net profit?
The current annual net income of RNAZ is -$18.55 M
What is the all time high annual net income for TransCode Therapeutics?
TransCode Therapeutics all-time high annual net profit is -$607.20 K
What is TransCode Therapeutics annual net income year-on-year change?
Over the past year, RNAZ annual net profit has changed by -$981.10 K (-5.59%)
What is TransCode Therapeutics quarterly net profit?
The current quarterly net income of RNAZ is -$2.32 M
What is the all time high quarterly net income for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly net profit is $2.77 M
What is TransCode Therapeutics quarterly net income year-on-year change?
Over the past year, RNAZ quarterly net profit has changed by +$2.98 M (+56.20%)
What is TransCode Therapeutics TTM net profit?
The current TTM net income of RNAZ is -$14.93 M
What is the all time high TTM net income for TransCode Therapeutics?
TransCode Therapeutics all-time high TTM net profit is -$41.30 K
What is TransCode Therapeutics TTM net income year-on-year change?
Over the past year, RNAZ TTM net profit has changed by +$4.67 M (+23.82%)